Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency.

O'Connor CM, Vanicek J, Murphy EA.

J Virol. 2014 May;88(10):5524-32. doi: 10.1128/JVI.00481-14. Epub 2014 Mar 5.

2.

Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.

Fu M, Gao Y, Zhou Q, Zhang Q, Peng Y, Tian K, Wang J, Zheng X.

Gene. 2014 Feb 25;536(2):272-8. doi: 10.1016/j.gene.2013.12.012. Epub 2013 Dec 18.

PMID:
24361963
3.

MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Jung YJ, Choi H, Kim H, Lee SK.

J Virol. 2014 Aug;88(16):9027-37. doi: 10.1128/JVI.00721-14. Epub 2014 Jun 4.

4.

A human herpesvirus 6A-encoded microRNA: role in viral lytic replication.

Nukui M, Mori Y, Murphy EA.

J Virol. 2015 Mar;89(5):2615-27. doi: 10.1128/JVI.02007-14. Epub 2014 Dec 17.

5.

Sleepless latency of human cytomegalovirus.

Poole E, Sinclair J.

Med Microbiol Immunol. 2015 Jun;204(3):421-9. doi: 10.1007/s00430-015-0401-6. Epub 2015 Mar 14. Review.

6.

Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.

Lu F, Stedman W, Yousef M, Renne R, Lieberman PM.

J Virol. 2010 Mar;84(6):2697-706. doi: 10.1128/JVI.01997-09. Epub 2010 Jan 13.

7.

Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells.

Lau B, Poole E, Van Damme E, Bunkens L, Sowash M, King H, Murphy E, Wills M, Van Loock M, Sinclair J.

J Gen Virol. 2016 Sep;97(9):2387-2398. doi: 10.1099/jgv.0.000546. Epub 2016 Jul 13.

8.

Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5.

Pan C, Zhu D, Wang Y, Li L, Li D, Liu F, Zhang CY, Zen K.

PLoS Pathog. 2016 Nov 8;12(11):e1006007. doi: 10.1371/journal.ppat.1006007. eCollection 2016 Nov.

9.

Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.

Shen ZZ, Pan X, Miao LF, Ye HQ, Chavanas S, Davrinche C, McVoy M, Luo MH.

PLoS One. 2014 Feb 12;9(2):e88531. doi: 10.1371/journal.pone.0088531. eCollection 2014.

10.

Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.

Humby MS, O'Connor CM.

J Virol. 2015 Dec 30;90(6):2959-70. doi: 10.1128/JVI.02507-15.

11.

Analysis of human cytomegalovirus-encoded microRNA activity during infection.

Stern-Ginossar N, Saleh N, Goldberg MD, Prichard M, Wolf DG, Mandelboim O.

J Virol. 2009 Oct;83(20):10684-93. doi: 10.1128/JVI.01292-09. Epub 2009 Aug 5.

12.

Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Saffert RT, Penkert RR, Kalejta RF.

J Virol. 2010 Jun;84(11):5594-604. doi: 10.1128/JVI.00348-10. Epub 2010 Mar 24.

13.

Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 Secretion during latent infection through changes in the cellular microRNA hsa-miR-92a.

Poole E, Avdic S, Hodkinson J, Jackson S, Wills M, Slobedman B, Sinclair J.

J Virol. 2014 Dec;88(24):13947-55. doi: 10.1128/JVI.02424-14. Epub 2014 Sep 24.

14.

Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34⁺ progenitors.

Poole E, McGregor Dallas SR, Colston J, Joseph RS, Sinclair J.

J Gen Virol. 2011 Jul;92(Pt 7):1539-49. doi: 10.1099/vir.0.031377-0. Epub 2011 Apr 6.

PMID:
21471310
15.

Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Kim JH, Collins-McMillen D, Buehler JC, Goodrum FD, Yurochko AD.

J Virol. 2017 Feb 14;91(5). pii: e01206-16. doi: 10.1128/JVI.01206-16. Print 2017 Mar 1.

16.

RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.

Xiaofei E, Stadler BM, Debatis M, Wang S, Lu S, Kowalik TF.

J Virol. 2012 May;86(10):5660-73. doi: 10.1128/JVI.06338-11. Epub 2012 Mar 21.

17.

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D.

J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11.

18.

Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Rak MA, Buehler J, Zeltzer S, Reitsma J, Molina B, Terhune S, Goodrum F.

J Virol. 2018 Sep 26;92(20). pii: e00919-18. doi: 10.1128/JVI.00919-18. Print 2018 Oct 15.

19.

HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.

Keyes LR, Hargett D, Soland M, Bego MG, Rossetto CC, Almeida-Porada G, St Jeor S.

PLoS One. 2012;7(12):e52827. doi: 10.1371/journal.pone.0052827. Epub 2012 Dec 26.

Supplemental Content

Support Center